{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:46:17Z","timestamp":1767887177669,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bbagen.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T12:57:18Z","timestamp":1170075438000},"page":"797-809","source":"Crossref","is-referenced-by-count":89,"title":["The drug binding site of human \u03b11-acid glycoprotein: Insight from induced circular dichroism and electronic absorption spectra"],"prefix":"10.1016","volume":"1770","author":[{"given":"Ferenc","family":"Zsila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2007.01.009_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0031-6997(24)01447-9","article-title":"Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands","volume":"52","author":"de Wolf","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2007.01.009_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2133\/dmpk.20.309","article-title":"A molecular functional study on the interactions of drugs with plasma proteins","volume":"20","author":"Otagiri","year":"2005","journal-title":"Drug Metab. Pharmacokineti."},{"key":"10.1016\/j.bbagen.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human \u03b11-glycoprotein and its interactions with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbagen.2007.01.009_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s004390050378","article-title":"Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S","volume":"99","author":"Yuasa","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbagen.2007.01.009_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/mol.54.1.129","article-title":"Ligand specificity of the genetic variants of human \u03b11-acid glycoprotein: generation of a three-dimensional quantitative structure\u2013activity relationship model for drug binding to the A variant","volume":"54","author":"Herv\u00e9","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-2125.2003.01909.x","article-title":"Differential binding of disopyramide and warfarin enantiomers to human \u03b11-acid glycoprotein variants","volume":"56","author":"Nakagawa","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bcp.2003.09.039","article-title":"Specific ligand binding on genetic variants of human \u03b11-acid glycoprotein studied by circular dichroism spectroscopy","volume":"67","author":"Fitos","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-291X(02)02765-1","article-title":"Structure of human \u03b11-acid glycoprotein and its high-affinity binding site","volume":"300","author":"Kopecky","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2007.01.009_bib9","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.carres.2006.07.012","article-title":"Progesterone binding to the tryptophan residues of human \u03b11-acid glycoprotein","volume":"341","author":"Albani","year":"2006","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbapap.2005.12.006","article-title":"Comparative ligand-binding analysis of ten human lipocalins","volume":"1764","author":"Breustedt","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2007.01.009_bib11","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.bbagen.2006.08.015","article-title":"Selective binding of imatinib to the genetic variants of human \u03b11-acid glycoprotein","volume":"1760","author":"Fitos","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2007.01.009_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bioorg.2005.03.003","article-title":"Circular dichroism and absorption spectroscopic data reveal binding of the natural cis-carotenoid bixin to human \u03b11-acid glycoprotein","volume":"33","author":"Zsila","year":"2005","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbagen.2007.01.009_bib13","first-page":"3239","article-title":"Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human \u03b11-acid glycoprotein","volume":"12","author":"Zsila","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbagen.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.2042-7158.1982.tb04212.x","article-title":"Optical studies on the specific interaction of dipyridamole with \u03b11-acid glycoprotein (orosomucoid)","volume":"34","author":"El-Gamal","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jps.2600720229","article-title":"Binding of several phenothiazine neuroleptics to a common binding site of \u03b11-acid glycoprotein, orosomucoid","volume":"72","author":"El-Gamal","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.2042-7158.1985.tb05071.x","article-title":"Prazosin binding to human \u03b11-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the \u2018single drug binding site' of orosomucoid","volume":"37","author":"Brunner","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1023\/A:1015936710919","article-title":"Drug binding to \u03b11-acid glycoprotein studied by circular dichroism","volume":"6","author":"Otagiri","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1015880327911","article-title":"Reversal of signs of induced cotton effects of dicumarol-\u03b11-acid glycoprotein systems by phenothiazine neuroleptics through ternary complexation","volume":"9","author":"Miyoshi","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib19","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/0006-2952(92)90175-I","article-title":"Further characterization of reversal of signs of induced cotton effects of dicumarol derivatives-\u03b11-acid glycoprotein systems by protriptyline","volume":"43","author":"Miyoshi","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0006-2952(91)90029-5","article-title":"Effects of tricyclic drug on induced circular dichroism spectra of dicumarol bound to \u03b11-acid glycoprotein","volume":"42","author":"Otagiri","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1248\/cpb.38.1688","article-title":"Characterization of drug binding sites on \u03b11-acid glycoprotein","volume":"38","author":"Maruyama","year":"1990","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.2042-7158.1987.tb03412.x","article-title":"A comparative study of the interaction of warfarin with human \u03b11-acid glycoprotein and human albumin","volume":"39","author":"Otagiri","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1074\/jbc.M411076200","article-title":"Use of photoaffinity labeling and site-directed mutagenesis for identification of the key residue responsible for extraordinarily high affinity binding of UCN-01 in human \u03b11-acid glycoprotein","volume":"280","author":"Katsuki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2007.01.009_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/ja01097a017","article-title":"Preparation and properties of serum and plasma proteins. XXIX. Separation from human plasma of polysaccharides, peptides and proteins of low molecular weight. Crystallization of an acid glycoprotein","volume":"75","author":"Schmid","year":"1953","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2007.01.009_bib25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jps.1093","article-title":"Development of a novel probe for measuring drug binding to the F1*S variant of human \u03b11-acid glycoprotein","volume":"90","author":"Cogswell","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00008571-199610000-00004","article-title":"Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human \u03b11-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on \u03b11-acid glycoprotein","volume":"6","author":"Herv\u00e9","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2007.01.009_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10557-005-4659-6","article-title":"Dipyridamole, an underestimated vascular protective drug","volume":"19","author":"Schaper","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbagen.2007.01.009_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-2313(92)90060-M","article-title":"Electronic absorption and fluorescence spectroscopic studies of dipyridamole: effects of solution composition","volume":"51","author":"Borisevitch","year":"1992","journal-title":"J. Lumin."},{"key":"10.1016\/j.bbagen.2007.01.009_bib29","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/0584-8539(95)01432-2","article-title":"Synthesis, characterization and interaction with ionic micelles of tetraacetylated dipyridamole","volume":"51","author":"Borges","year":"1995","journal-title":"Spectrochim. Acta, A"},{"key":"10.1016\/j.bbagen.2007.01.009_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(86)90847-8","article-title":"Pharmacokinetics of terazosin","volume":"80","author":"Sonders","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbagen.2007.01.009_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<751::AID-JPS6>3.0.CO;2-8","article-title":"Enantioselective binding of propranolol, disopyramide, and verapamil to human \u03b11-acid glycoprotein","volume":"89","author":"Hanada","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2007.01.009_bib32","first-page":"871","article-title":"Distribution of primaquine in human blood: drug-binding to \u03b11-acid glycoprotein","volume":"116","author":"Kennedy","year":"1990","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbagen.2007.01.009_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/chir.530040108","article-title":"Enantioselective chromatography of the antimalarial agents chloroquine, mefloquine, and enpiroline on a \u03b11-acid glycoprotein chiral stationary phase: evidence for a multiple-site chiral recognition mechanism","volume":"4","author":"Aubry","year":"1992","journal-title":"Chirality"},{"key":"10.1016\/j.bbagen.2007.01.009_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2125.1984.tb02496.x","article-title":"Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and \u03b11-acid glycoprotein","volume":"18","author":"MacKichan","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01186254","article-title":"X-ray crystallographic characterization of 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide","volume":"22","author":"Bandoli","year":"1992","journal-title":"J. Crystallogr. Spectrosc. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib36","doi-asserted-by":"crossref","first-page":"15943","DOI":"10.1021\/bi00049a009","article-title":"Conformation of xanthene dyes in the sulfhydryl 1 binding site of myosin 2","volume":"34","author":"Ajtai","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2007.01.009_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/jcis.2000.7273","article-title":"Characterization of the chromophore orientation of rhodamine B amphiphiles in Langmuir\u2013Blodgett monolayers","volume":"233","author":"Ishibashi","year":"2001","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bbagen.2007.01.009_bib38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/BF00754136","article-title":"Crystal structure of the 1:2.5 molecular complex of the internal salt of [6-(diethylamino)-9-[2-(fluorosulfonyl)-4-sulfophenyl]-3h-xanthen-3-ylidene]diethylammonium hydroxide with ethanol","volume":"26","author":"Polyakova","year":"1985","journal-title":"J. Struct. Chem."},{"key":"10.1016\/j.bbagen.2007.01.009_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/meth.1999.0927","article-title":"Optical spectroscopy in studies of antibody\u2013hapten interactions","volume":"20","author":"Tetin","year":"2000","journal-title":"Methods"},{"key":"10.1016\/j.bbagen.2007.01.009_bib40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbagen.2006.04.006","article-title":"Multiple ligand-binding properties of the lipocalin member chicken \u03b11-acid glycoprotein studied by circular dichroism and electronic absorption spectroscopy: the essential role of the conserved tryptophan residue","volume":"1760","author":"Zsila","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2007.01.009_bib41","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/S0957-4166(01)00552-3","article-title":"Induced chirality upon crocetin binding to human serum albumin: origin and nature","volume":"12","author":"Zsila","year":"2001","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1016\/j.bbagen.2007.01.009_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0076-6879(04)83013-1","article-title":"Computation and analysis of protein circular dichroism spectra","volume":"383","author":"Sreerama","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1039\/tf9716700966","article-title":"Linear and circular dichroism studies of DNA\u2013monoaminoacridine complexes","volume":"67","author":"Jackson","year":"1971","journal-title":"Trans. Faraday Soc."},{"key":"10.1016\/j.bbagen.2007.01.009_bib44","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1039\/b108575c","article-title":"The pH dependence of the anisotropy factors of essential amino acids","volume":"2","author":"Nishino","year":"2002","journal-title":"J. Chem. Soc., Perkin. Trans."},{"key":"10.1016\/j.bbagen.2007.01.009_bib45","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/j100589a016","article-title":"Dependence of exciton circular dichroism amplitudes on oscillator strength","volume":"79","author":"Heyn","year":"1975","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.bbagen.2007.01.009_bib46","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1021\/ja00852a005","article-title":"Quantitative definition of exciton chirality and the distant effect in the exciton chirality method","volume":"97","author":"Harada","year":"1975","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2007.01.009_bib47","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj2320863","article-title":"Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents","volume":"232","author":"Friedman","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2007.01.009_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02278765","article-title":"The lipocalin model for human orosomucoid: support from the chromatography of orosomucoid\u2013monoclonal antibody complexes","volume":"39","author":"Villalobos","year":"1994","journal-title":"Chromatographia"},{"key":"10.1016\/j.bbagen.2007.01.009_bib49","first-page":"363","article-title":"Drug binding sites on human \u03b11-acid glycoprotein","volume":"300","author":"M\u00fcller","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib50","first-page":"1","article-title":"Drug binding to human alpha-1-acid glycoprotein in health and disease","volume":"40","author":"Kremer","year":"1988","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2007.01.009_bib51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.carres.2003.10.016","article-title":"Tertiary structure of human \u03b11-acid glycoprotein (orosomucoid). Straightforward fluorescence experiments revealing the presence of a binding pocket","volume":"339","author":"Albani","year":"2004","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib52","unstructured":"J.P. Schwegmann, The study of tryptophan residues in human orosomucoid and their involvement in the basic drug binding site, M.Sc. Thesis, University of Cincinnati, Cincinnati, United States, 1985."},{"key":"10.1016\/j.bbagen.2007.01.009_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1135\/cccc19840165","article-title":"The tyrosyl and tryptophyl residues of orosomucoid studied by difference and derivative spectrophotometry","volume":"49","author":"Kalal","year":"1984","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.bbagen.2007.01.009_bib54","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/bi00656a001","article-title":"Topography of human plasma \u03b11-acid glycoprotein","volume":"15","author":"Schmid","year":"1976","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2007.01.009_bib55","first-page":"A409","article-title":"The basic drug-binding site of human orosomucoid","volume":"47","author":"Friedman","year":"1985","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2007.01.009_bib56","first-page":"A268","article-title":"Fluorescence studies of the interaction of basic drugs with human orosomucoid","volume":"41","author":"Halsall","year":"1983","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2007.01.009_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1992.tb14358.x","article-title":"Investigation of the interaction mode of phenothiazine neuroleptics with \u03b11-acid glycoprotein","volume":"44","author":"Miyoshi","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib58","first-page":"67","article-title":"Monoclonal antibodies against human orosomucoid: tools for the exploration of structure, function and interactions","volume":"300","author":"Halsall","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.bbagen.2007.01.009_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.2042-7158.1987.tb06960.x","article-title":"Inhibitory effect of phenothiazines on the binding of [3H]perazine to \u03b11-acid glycoprotein","volume":"39","author":"Schley","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib60","unstructured":"A.I. Bencosme, Photoaffinity labelling the basic binding site of orosomucoid, Ph.D. Thesis University of Cincinnati, Cincinnati, United States, 1992."},{"key":"10.1016\/j.bbagen.2007.01.009_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0005-2795(76)90358-5","article-title":"Steroid\u2013protein interactions. XXXIV. Chemical modification of \u03b11-acid glycoprotein for characterization of the progesterone binding site","volume":"420","author":"Kute","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2007.01.009_bib62","unstructured":"J.A. Wallace, Photoaffinity labeling of the progesterone binding site of human orosomucoid, PhD thesis, University of Cincinnati, Cincinnati, United States, 1982."},{"key":"10.1016\/j.bbagen.2007.01.009_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0006-2952(86)90357-6","article-title":"Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG)","volume":"35","author":"McNamara","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00512392","article-title":"Characterization of a common binding site for basic drugs on human alpha1-acid glycoprotein (orosomucoid)","volume":"322","author":"M\u00fcller","year":"1983","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.01.009_bib65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jps.2600750208","article-title":"Interaction between antidepressants and alpha1-adrenergic receptor antagonists on the binding to alpha1-acid glycoprotein","volume":"75","author":"Ferry","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2007.01.009_bib66","first-page":"1656","article-title":"The crystal structure of phenothiazine","author":"Bell","year":"1968","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbagen.2007.01.009_bib67","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/la991297l","article-title":"Calorimetry studies of chlorpromazine hydrochloride in solution","volume":"16","author":"Saito","year":"2000","journal-title":"Langmuir"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416507000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416507000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T07:05:20Z","timestamp":1736751920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416507000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0304416507000347"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2007.01.009","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}